Abstract
An association between renal microvascular complications and hemorheological alterations has been suggested in diabetes mellitus. Therefore, a hemorheologic approach in the treatment of diabetic microproteinuria has been proposed. Eighty-two type I and type II diabetic patients with microproteinuria were randomized and assigned to two different protocols: protocol A, patients treated with pentoxifylline (Trental 400); protocol B, patients without hemorheologic treatment, in whom hypoglycemic therapy was just more strictly enforced. A significant improvement of the hemorheologic pattern and a significant marked reduction of albumin excretion rate and proteinuria was found in diabetic patients treated with pentoxifylline, independently of the degree of metabolic control. These results were readily achieved and were confirmed throughout the study. Moreover, these results were comparable to those obtained in diabetic patients of protocol B. Pentoxifylline might therefore be considered as the first useful therapeutic agent in the treatment of diabetic microproteinuria.
References
Mar 22, 1979·The New England Journal of Medicine·G C VibertiH Keen
May 7, 1976·Analytical Biochemistry·M M Bradford
Sep 1, 1976·Journal of Clinical Pathology·H L ReidT L Dormandy
Jun 1, 1985·The Journal of Clinical Endocrinology and Metabolism·E EsmatjesD Figuerola
Jul 1, 1985·Acta diabetologica latina·S B SolerteE Ferrari
Mar 7, 1985·The New England Journal of Medicine·M J WisemanG Viberti
Jan 1, 1985·Nephron·L O Simpson
Sep 1, 1965·Immunochemistry·G ManciniJ F Heremans
Jun 26, 1982·Lancet·G C VibertiH Keen
Jul 1, 1984·Diabetes·G Viberti, H Keen
Jun 1, 1984·Diabetologia·M WisemanH Keen
Feb 9, 1984·The New England Journal of Medicine·C E Mogensen
Jul 12, 1984·The New England Journal of Medicine·C E Mogensen, C K Christensen
Nov 1, 1982·Diabetes Care·J C PickupA H Rubenstein
Oct 1, 1980·Diabetologia·R B PaiseyT Chadwick
Jan 1, 1983·Angiology·T Di Perri, M Guerrini
Jan 1, 1980·La Ricerca in Clinica E in Laboratorio·J T Whicher, E S Parry
May 1, 1982·Kidney International·G C VibertiH Keen
Jan 1, 1982·Nephron·L O Simpson
Oct 1, 1981·Diabetologia·J S ChristiansenH H Parving
Citations
Jul 1, 1987·Acta diabetologica latina·S B SolerteE Ferrari
Nov 19, 2009·Inflammation·Kum Hyun HanDae Ryong Cha
Jul 29, 1998·Medical Hypotheses·M F McCarty
Oct 8, 2008·Acta Diabetologica·Boglárka LaczyIstván Wittmann
Apr 9, 2005·Journal of the Chinese Medical Association : JCMA·Shuei-Liong LinBor-Shen Hsieh
Mar 3, 2009·Cytokine & Growth Factor Reviews·Juan F Navarro-GonzálezJavier García
Feb 14, 2009·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·Robert M PerkinsChristina M Yuan
Sep 15, 2004·Nephrology·Shuei-Liong LinWan-Yu Chen
Jun 18, 2015·Clinical Pharmacology and Therapeutics·P-C WuUNKNOWN Kidney Consortium
Jun 13, 2015·Journal of Diabetes Research·Stephanie Toth-Manikowski, Mohamed G Atta
May 1, 1995·European Journal of Vascular and Endovascular Surgery : the Official Journal of the European Society for Vascular Surgery
Mar 19, 2015·Journal of Diabetes Research·Javier Donate-CorreaJuan F Navarro-González
May 27, 2005·Journal of the American Society of Nephrology : JASN·Juan F NavarroJavier García
May 4, 2011·Nature Reviews. Nephrology·Juan F Navarro-GonzálezJavier García-Pérez
Apr 7, 1990·BMJ : British Medical Journal·S BjörckM Aurell
Dec 17, 2004·Renal Failure·Zubeyde GunduzRecep Saraymen
Feb 18, 2012·The Cochrane Database of Systematic Reviews·Dan ShanGuan J Liu
May 16, 2019·Terapevticheskiĭ arkhiv·I T MurkamilovA A Bayzhigitova